Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Laboratories reports 3-fold jump in Q1 consolidated net profit

Date: 29-07-2022

Dr. Reddy's Laboratories has reported results for first quarter ended June 30, 2022.

The company has reported a rise of 20.83% in its net profit at Rs 499.50 crore for the quarter under review as compared to Rs 413.40 crore for the same quarter in the previous year. Total income of the company increased by 11.45% at Rs 4,034 crore for Q1FY23 as compared Rs 3,619.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 3-fold jump in its net profit at Rs 1,189 crore for the quarter under review as compared to Rs 380.40 crore for the same quarter in the previous year. Total income of the company increased by 20.46% at Rs 6,086.80 crore for Q1FY23 as compared Rs 5,053 crore for the corresponding quarter previous year.